7:07 am BioLineRx: co announces that professor has received final regulatory approval to evaluate BL-8040 as a treatment for chronic myeloid leukemia
View todays social media effects on BLRX
View the latest stocks trending across Twitter. Click to view dashboard
See who BioLineRx is hiring next, click here to view
